Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adri C Voogd

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United StatesStefano Rosso, Adam Gondos, Roberto Zanetti, et al.
European Radiology|April 21, 2015
Discrepant screening mammography assessments at blinded and non-blinded double reading: impact of arbitration by a third reader on screening outcomeElisabeth G Klompenhouwer, Adri C Voogd, Gerard J den Heeten, et al.
Annals of Surgical Oncology|September 4, 2012
Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration studyAdriana J G Maaskant-Braat, Rudi M H Roumen, Adri C Voogd, et al.
Breast (Edinburgh, Scotland)|November 30, 2024
Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS componentRoxanne A W Ploumen, Thiemo J A van Nijnatten, Loes F S Kooreman, et al.
Breast Cancer Research and Treatment|May 10, 2011
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based studyWikke Setz-Pels, Lucien E M Duijm, Johanna H Groenewoud, et al.
Annals of Surgical Oncology|March 10, 2019
Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor RecurrenceIngrid G M Poodt, Coco J E F Walstra, Guusje Vugts, et al.
European Radiology|June 27, 2018
Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammographyAngela M P Coolen, Joost R C Lameijer, Adri C Voogd, et al.
Breast Cancer Research and Treatment|May 7, 2018
Incorporation of the technologist's opinion for arbitration of discrepant assessments among radiologists at screening mammographyAngela M P Coolen, Joost R C Lameijer, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern NetherlandsMyrthe P P Sukel, Lonneke V van de Poll-Franse, Grard A P Nieuwenhuijzen, et al.
European Radiology|April 19, 2018
Frequency and characteristics of contralateral breast abnormalities following recall at screening mammographyJoost R C Lameijer, Angela Mp Coolen, Adri C Voogd, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United StatesStefano Rosso, Adam Gondos, Roberto Zanetti, et al.
European Radiology|April 21, 2015
Discrepant screening mammography assessments at blinded and non-blinded double reading: impact of arbitration by a third reader on screening outcomeElisabeth G Klompenhouwer, Adri C Voogd, Gerard J den Heeten, et al.
Annals of Surgical Oncology|September 4, 2012
Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration studyAdriana J G Maaskant-Braat, Rudi M H Roumen, Adri C Voogd, et al.
Breast (Edinburgh, Scotland)|November 30, 2024
Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS componentRoxanne A W Ploumen, Thiemo J A van Nijnatten, Loes F S Kooreman, et al.
Breast Cancer Research and Treatment|May 10, 2011
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based studyWikke Setz-Pels, Lucien E M Duijm, Johanna H Groenewoud, et al.
Annals of Surgical Oncology|March 10, 2019
Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor RecurrenceIngrid G M Poodt, Coco J E F Walstra, Guusje Vugts, et al.
European Radiology|June 27, 2018
Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammographyAngela M P Coolen, Joost R C Lameijer, Adri C Voogd, et al.
Breast Cancer Research and Treatment|May 7, 2018
Incorporation of the technologist's opinion for arbitration of discrepant assessments among radiologists at screening mammographyAngela M P Coolen, Joost R C Lameijer, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern NetherlandsMyrthe P P Sukel, Lonneke V van de Poll-Franse, Grard A P Nieuwenhuijzen, et al.
European Radiology|April 19, 2018
Frequency and characteristics of contralateral breast abnormalities following recall at screening mammographyJoost R C Lameijer, Angela Mp Coolen, Adri C Voogd, et al.
Pageof 16